Insights into the clinical management of carbapenem-resistant Gram-negative infections: An Italian retrospective clinical chart review

Insights into the clinical management of carbapenem-resistant Gram-negative infections: An Italian retrospective clinical chart review

There is a lack of consensus regarding management of infections with carbapenem- resistant Gram-negative (CR-GN) pathogens. This study comprised a medical chart review to assess patient management in a high CR prevalence setting. Data was collated retrospectively from medical records of patients ho...

Full description

Bibliographic Details
Main Authors:	Guido Granata, Davide Manissero, Maria Vittoria Oppia, Keiko Tone, Bin Cai, Christopher Longshaw, Carolina Venditti, Nicola Petrosillo
Format:	Article
Language:	English
Published:	MDPI AG 2020-08-01
Series:	Infectious Disease Reports
Subjects:	Antibiotic resistance carbapenem resistance multi-drug resistance Gram-negative bacteria clinical management
Online Access:	https://www.pagepress.org/journals/index.php/idr/article/view/8510

Similar Items

Molecular characterization of carbapenem-resistant Gram-negative bacilli clinical isolates in Algeria
by: Bourafa N, et al.
Published: (2018-05-01)

The threat of carbapenem-resistant gram-negative bacteria in a Middle East region
by: Davoudi-Monfared E, et al.
Published: (2018-10-01)

In vitro activity of cefiderocol and comparators against Gram-negative bacterial isolates from a series of surveillance studies in England: 2014–2018
by: Vanya Gant, et al.
Published: (2021-12-01)

In vitro activity of cefiderocol and comparators against isolates of Gram-negative pathogens from a range of infection sources: SIDERO-WT-2014–2018 studies in Italy
by: Stefano Stracquadanio, et al.
Published: (2021-06-01)

In vitro activity of cefiderocol and comparators against isolates of Gram-negative bacterial pathogens from a range of infection sources: SIDERO‑WT‑2014−2018 studies in Spain
by: Emilia Cercenado, et al.
Published: (2021-09-01)

Treatment outcome and adverse effects of colistin in adult patients with carbapenem-resistant gram-negative bacteremia from Pakistan
by: Zaheer Udin Babar, et al.
Published: (2021-05-01)

The role of combination therapy in the treatment of severe infections caused by carbapenem resistant gram-negatives: a systematic review of clinical studies
by: Alessia Savoldi, et al.
Published: (2021-06-01)

Antibiogram and Genetic Characterization of Carbapenem-Resistant Gram-Negative Pathogens Incriminated in Healthcare-Associated Infections
by: Makharita RR, et al.
Published: (2020-11-01)

Phenotypic Detection of Carbapenem-Resistant Gram-Negative Bacilli from a Clinical Specimen in Sidama, Ethiopia: A Cross-Sectional Study
by: Alemayehu T, et al.
Published: (2021-02-01)

Carbapenem Resistance: A Review
by: Francis S. Codjoe, et al.
Published: (2017-12-01)

Clinical profile and outcome of carbapenem-resistant gram negative bacteremia in children with cancer in pediatric intensive care unit of a resource-limited country
by: Uzair Ali Memon, et al.
Published: (2020-09-01)

Trends and correlation between antibacterial consumption and carbapenem resistance in gram-negative bacteria in a tertiary hospital in China from 2012 to 2019
by: Chunhong Liang, et al.
Published: (2021-05-01)

Carbapenem-resistant Gram-negative bacteria – analysis of the data obtained through a mandatory reporting system in the Rhine-Main region, Germany, 2012–2015
by: Heudorf, Ursel, et al.
Published: (2016-04-01)

Burden of carbapenem non-susceptible infections in high-risk patients: systematic literature review and meta-analysis
by: Esther E. Avendano, et al.
Published: (2020-12-01)

Global Distribution Patterns of Carbapenemase-Encoding Bacteria in a New Light: Clues on a Role for Ethnicity
by: Claudio Neidhöfer, et al.
Published: (2021-06-01)

Risk Factors of Bloodstream Infections Caused by Carbapenem-resistant Gram-negative Pathogens in Pediatric Critical Care Settings
by: Zümrüt Şahbudak Bal, et al.
Published: (2019-09-01)

Association of Carbapenem and Colistin Resistance in Pathogenic Gram Negative Bacteria
by: Reham Osama, et al.
Published: (2019-06-01)

Efficacy and safety of polymyxin B in carbapenem-resistant gram-negative organisms infections
by: G. L. Xia, et al.
Published: (2021-10-01)

Characterisation of carbapenem-resistant Gram-negative organisms from clinical specimens in Yola, Nigeria
by: Shuwaram A. Shettima, et al.
Published: (2020-06-01)

Impact of an Antimicrobial Stewardship Program on the Incidence of Carbapenem Resistant Gram-Negative Bacilli: An Interrupted Time-Series Analysis
by: Teresa López-Viñau, et al.
Published: (2021-05-01)

Carbapenem Resistance in Non-Fermentative Gram-Negative Bacilli Isolated from Intensive Care Unit Patients of a Referral Hospital
by: Santosh Kumar Yadav, et al.
Published: (2021-04-01)

The world-wide spread of carbapenem-resistant Enterobacterales
by: Arjana TAMBIC ANDRASEVIC, et al.
Published: (2021-04-01)

The world-wide spread of carbapenem-resistant Enterobacterales
by: Arjana TAMBIC ANDRASEVIC, et al.
Published: (2021-04-01)

Carbapenem-Resistant Enterobacteriaceae Posing a Dilemma in Effective Healthcare Delivery
by: Angus Nnamdi Oli, et al.
Published: (2019-09-01)

In Vitro Activities of Colistin and Sitafloxacin Combinations against Multidrug-, Carbapenem-, and Colistin-Resistant <i>Acinetobacter baumannii</i> Using the Broth Microdilution Checkerboard and Time-Kill Methods
by: Vipavee Rodjun, et al.
Published: (2020-08-01)

Prevalence of carbapenem resistance among multidrug-resistant Gram-negative uropathogens
by: Ann A. Elshamy, et al.
Published: (2018-12-01)

Double-carbapenem therapy in the treatment of multidrug resistant Gram-negative bacterial infections: a systematic review and meta-analysis
by: Yuan-yuan Li, et al.
Published: (2020-06-01)

Infection control management and surveillance of carbapenem-resistant Gram-negative bacteria in hematopoietic stem cell recipients
by: Claas Baier, et al.
Published: (2019-10-01)

Alternative drugs against multiresistant Gram-negative bacteria
by: Lauro Vieira Perdigão Neto, et al.
Published: (2020-12-01)

Predictors of Mortality in Patients with Carbapenem-Resistant Gram-Negative Bacilli or Vancomycin-Resistant Enterococci Bacteremia
by: Shi HJ, et al.
Published: (2020-10-01)

Results on the mandatory notification of carbapenem-resistant Gram-negative bacteria, Hesse, Germany, January 2012 – April 2013
by: Hauri, Anja M., et al.
Published: (2014-04-01)

A Cohort Study of the Impact of Carbapenem-Resistant Enterobacteriaceae Infections on Mortality of Patients Presenting with Sepsis
by: Sabrina Sabino, et al.
Published: (2019-04-01)

Carbapenem-Resistant Enterobacteria: How to Cope?
by: Füsun Zeynep Akçam
Published: (2019-06-01)

Carbapenemase Producers Among Extensive Drug-Resistant Gram-Negative Pathogens Recovered from Febrile Neutrophilic Patients in Egypt
by: Mabrouk S, et al.
Published: (2020-09-01)

Screening for carriage of carbapenem-resistant Enterobacteriaceae in settings of high endemicity: a position paper from an Italian working group on CRE infections
by: Simone Ambretti, et al.
Published: (2019-08-01)

Carbapenem-Resistant Enterobacteriaceae among In-Patients of Tertiary Hospitals in Southwest, Nigeria
by: Ibikunle I. ANIBIJUWON, et al.
Published: (2018-09-01)

Clinical outcome of neonates with Carbapenem-resistant Enterobacteriaceae infections at the King Edward VIII Hospital’s neonatal unit, Durban, South Africa
by: Bongani W. Mzimela, et al.
Published: (2021-01-01)

Integrated pharmacokinetic–pharmacodynamic modeling to evaluate empiric carbapenem therapy in bloodstream infections
by: Lim TP, et al.
Published: (2018-09-01)

The role of hospital environment in transmissions of multidrug-resistant gram-negative organisms
by: Po Ying Chia, et al.
Published: (2020-02-01)

Ceftazidime-Avibactam Therapy Versus Ceftazidime-Avibactam-Based Combination Therapy in Patients With Carbapenem-Resistant Gram-Negative Pathogens: A Meta-Analysis
by: Dan Li, et al.
Published: (2021-09-01)